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Introduction. Whilst there are reports of viral myopathies aﬀecting children and the immunocompromised, infective myositis is a
relatively rare inflammatory myopathy in adults. The clinical spectrum can range from benign myalgias to more serious complica-
tions in certain risk groups. Case Presentation. We present two cases of myositis as a result of parvovirus B19 infection. Conclusion.
Viral myositis and parvovirus B19 associated myositis should be considered in adults presenting with significant myalgia.
1. Introduction
Myositis is an inflammatory myopathy mainly associated
with viral infection. The spectrum formed by the disease
means presentation can range from vague muscular pain,
swelling, and oedema to cardiac arrhythmias as a result of
electrolyte disturbances from severe rhabdomyolysis.
Of the suspected viral causes of myositis, parvovirus B19
is one of the least frequently recorded. This is thought to be a
result of the acquired immunity developed by most adults
over their lifetime. It follows that parvovirus B19 infects
children more frequently; however, children rarely develop
anything more than erythema infectiosum before recovery
[1]. We describe two adult cases that developed myositis as a
result of parvovirus B19 infection.
2. Case Presentation
The first patient is a 42-year-old Caucasian male who pre-
sented with a four-week history of pain in his calves asso-
ciated with inflammation, this soon progressed to involve
his thighs and had an associated weakness. He further des-
cribed ankle swelling, bilateral forearm pain, nocturnal
hyperhidrosis, and recent contact with children diagnosed
with “slapped cheek syndrome” associated with erythrovirus
B19 infection.
Physical examination revealed bilateral calf muscle hy-
pertrophy, with pitting oedema of the ankles. Both lower
limbs had decreased power (4/5) in all muscle groups.
Initial blood tests revealed an elevated C-reactive protein
and normal creatinine kinase. A muscle biopsy of the left
thigh was performed yielding no pathological diagnosis, and
a T2 and short TI inversion recovery MRI revealed bilateral
marked intramuscular septal oedema of the soleus muscles
and subcutaneous oedema of the lower legs. EMG showed
mild myopathic changes but no spontaneous fibrillation.
HIV/Hep B/C tests were negative; however, muscle biopsy
was seen to be PCR positive for erythrovirus B19 with
32900 cop/m. The patient commenced prednisolone with
significant clinical response within 2 weeks.
The second patient is a 46-year-old Caucasian male with
a background of antiphospholipid syndrome who presented
with a six-week history of sudden onset of bilateral elbow
pain which progressed to involve both calves. Inflamma-
tory markers were raised with erythrocyte sedimentation
rate 119mm/hr, C-reactive protein 34mg/L, and creatinine
kinase 187 IU/L.
On examination the only positive finding was tenderness
over the anterior quadriceps and calf muscles. MRI showed
significant intramuscular oedema in both legs (Figure 1).
Erythrovirus B19 IgM was positive, and PCR quantification
indicated strong positivity at 66400 cop/m. The patient was
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Figure 1: Coronal STIR MRI image showing high signal change in the right thigh associated with intramuscular oedema.
started on 40mg prednisolone PO OD, and on review one
week later the patient was significantly improved.
3. Discussion
Parvovirus B19 as a cause of myositis is rare and seldom
reported. Indeed, the first report was in rheumatology in
2000 [2]. In this case the authors described a patient with
inflammatory myopathy and parvovirus B19 DNA in two
muscle biopsies five months apart. Since then, there have
been as many reports denying any association between par-
vovirus B19 and myositis, as there have been to support it.
Indeed, some of the authors involved in the aforementioned
paper in support of an association have now come to believe
there is no link between myositis and parvovirus B19 [3].
This is because initial findings of the presence of parvovirus
B19 in the musculature of one patient with dermatomyositis
have been superseded by the lack of identification of B19
DNA in muscle biopsies in any of 8 patients with inflam-
matory myopathies.
In support of the association, the first case report is
strengthened by the fact that no other identifiable cause for
the dermatomyositis other than parvovirus B19 was found,
and the patient recovered with prednisolone and metho-
trexate treatment. However, the second case report under-
mines this slightly as it shows a lack of any B19 in any of 8
patients known to have inflammatory myopathy.
It has been shown that some 15% of newly diagnosed
arthritis is most likely caused by parvovirus infection [4].
We now present two cases of acute inflammatory myositis
without arthritis in association with acute erythrovirus B19
infection. We thus propose that there is a true association
with inflammatory myositis.
We highlight these cases to support the debate as to a true
association between parvovirus B19 infection and myositis,
but agree that more scientific study into the field is needed.
4. Conclusion
Parvovirus B19 infection is rare in adults. However, it should
be considered a potential causative factor in patients with
myositis. A larger-scale epidemiological study would be
useful to help ascertain whether, in fact, there is a true asso-
ciation between parvovirus B19 infection and myositis.
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